Fund+
People
- Board members
- Our team
Investment Strategy
Portfolio
- Current
- Exits
Your Project
News
Contact us

Coave

Coave Therapeutics announces Positive 12-months Data from Ongoing Phase I/II Clinical Trial of CTx-PDE6b in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b

Post by: Diane De wyngaert in Coave Press Release

- CTx-PDE6b demonstrated clinically meaningful…

05 Jun 2023

Coave Therapeutics Strengthens Board of Directors

Post by: Diane De wyngaert in Coave Press Release

Paris, France, October 20th, 2022…

20 Oct 2022

Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders

Post by: Diane De wyngaert in Coave Press Release

Coave Therapeutics to Collaborate with…

20 Sep 2022

Coave Therapeutics appoints Olivier Danos and Frederic Chereau as non-executive directors to its Board

Post by: Geert in Coave Press Release

Coave Therapeutics appoints Olivier Danos…

12 Oct 2021

Contact us

Address:
Groot Begijnhof 60
3000 Leuven
Belgium
Phone: +32 (0)16 90 50 00
Email: info@fundplus.be

Recent Articles

Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral Adrenoleukodystrophy
ONA Therapeutics Announces the Appointment of Dr Pamela Klein to its Board of Directors
Novadip reports promising interim results from its first-in-human proof-of-concept trial with NVDX3, a new game changer in the bone field

© 2019 FUND⁺- ALL RIGHTS RESERVED. |

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT Read More

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.